المؤلفون: Force, Thomas, Krause, Daniela S, Van Etten, Richard A

المصدر: Nature reviews. Cancer. 7(5)

مصطلحات موضوعية: Adaptor Proteins, Signal Transducing: antagonists & inhibitors, Antibodies, Monoclonal: adverse effects, Antibodies, Monoclonal, Humanized, Benzenesulfonates: adverse effects, Drug Delivery Systems, Enzyme Inhibitors: adverse effects, Heart: growth & development, physiology, Heart Diseases: chemically induced, Humans, Indoles: adverse effects, Models, Biological, Neoplasms: drug therapy, Niacinamide: analogs & derivatives, Phenylurea Compounds, Protein Kinase Inhibitors: adverse effects, Protein-Tyrosine Kinases: antagonists & inhibitors, Proto-Oncogene Proteins c-abl: antagonists & inhibitors, Pyridines: adverse effects, Pyrroles: adverse effects, Quinazolines: adverse effects

وصف الملف: application/pdf

الوصول الحر: https://escholarship.org/uc/item/69t9f9m6Test

المؤلفون: Awada, Ahmad, Hendlisz, Alain, Gil, Thierry, Bartholomeus, Sylvie, Mano, Max S., de Valeriola, Dominique, Strumberg, Dirk, Brendel, Erich, Haase, Claus G, Schwartz, Brian, Piccart-Gebhart, Martine

المصدر: British Journal of Cancer, 92 (10

مصطلحات موضوعية: Sciences bio-médicales et agricoles, Adult, Aged, Benzenesulfonates -- administration & dosage, Benzenesulfonates -- adverse effects, Benzenesulfonates -- pharmacokinetics, Carcinoma, Renal Cell -- drug therapy, Drug Administration Schedule, Female, Humans, Kidney Neoplasms -- drug therapy, Male, Maximum Tolerated Dose, Middle Aged, Neoplasms -- drug therapy, Pyridines -- administration & dosage, Pyridines -- adverse effects, Pyridines -- pharmacokinetics, BAY 43-9006, Efficacy, Pharmacokinetics, Safety, Solid tumours, Targeted agent

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1038/sj.bjc.6602584; uri/info:pii/6602584; uri/info:pmid/15870716; uri/info:scp/20344362911; uri/info:pmcid/PMC2361774; https://dipot.ulb.ac.be/dspace/bitstream/2013/53723/4/doi_29057.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53723Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53723Test

المؤلفون: Dominique de Valeriola, E. Brendel, Martine Piccart, Thierry Gil, M Mano, C. G. Haase, Brian Schwartz, S. Bartholomeus, Dirk Strumberg, Ahmad Awada, Alain Hendlisz

المصدر: British Journal of Cancer, 92 (10
British Journal of Cancer

مصطلحات موضوعية: Male, Cancer Research, Pyridines, efficacy, Benzenesulfonates -- pharmacokinetics, Pyridines -- pharmacokinetics, Gastroenterology, Benzenesulfonates -- administration & dosage, Renal cell carcinoma, Neoplasms, Pyridines -- adverse effects, Clinical Studies, Pyridines -- administration & dosage, solid tumours, Benzenesulfonates, Sorafenib, Sciences bio-médicales et agricoles, Middle Aged, Kidney Neoplasms, Oncology, Female, Safety, Off Treatment, pharmacokinetics, medicine.drug, Niacinamide, safety, Adult, medicine.medical_specialty, Benzenesulfonates -- adverse effects, Maximum Tolerated Dose, Efficacy, Drug Administration Schedule, Pharmacokinetics, Refractory, Kidney Neoplasms -- drug therapy, Internal medicine, Carcinoma, medicine, Humans, Adverse effect, Carcinoma, Renal Cell, Aged, Solid tumours, targeted agent, business.industry, Phenylurea Compounds, medicine.disease, Carcinoma, Renal Cell -- drug therapy, Surgery, Neoplasms -- drug therapy, business, Bay, BAY 43-9006, Targeted agent

وصف الملف: 1 full-text file(s): application/pdf

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bbdf7ffc381de061c888c7a31dedc122Test
https://doi.org/10.1038/sj.bjc.6602584Test

المؤلفون: Verset, Gontran, Marechal, Raphaël, Bali, Maria Antonietta, Devière, Jacques, Van Laethem, Jean-Luc

المصدر: Annals of oncology, 21 (6

مصطلحات موضوعية: Sciences humaines, Antineoplastic Agents -- adverse effects -- therapeutic use, Benzenesulfonates -- adverse effects -- therapeutic use, Biliary Tract Neoplasms -- complications -- drug therapy -- secondary -- surgery, Biliary Tract Surgical Procedures -- adverse effects, Carcinoma, Hepatocellular -- complications -- drug therapy -- pathology -- surgery, Disease Progression, Fatal Outcome, Hemobilia -- etiology, Humans, Liver Neoplasms -- complications -- drug therapy -- pathology -- surgery, Pyridines -- adverse effects -- therapeutic use, Stents -- adverse effects

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1093/annonc/mdq071; uri/info:pii/mdq071; uri/info:pmid/20332137; uri/info:scp/77954015508; https://dipot.ulb.ac.be/dspace/bitstream/2013/139410/3/doi_122450.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/139410Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/139410Test

المؤلفون: Takimoto, Chris H, Awada, Ahmad

المصدر: Cancer chemotherapy and pharmacology, 61 (4

مصطلحات موضوعية: Sciences bio-médicales et agricoles, Animals, Antineoplastic Agents -- adverse effects, Antineoplastic Agents -- pharmacokinetics, Antineoplastic Agents -- pharmacology, Antineoplastic Agents -- toxicity, Antineoplastic Combined Chemotherapy Protocols -- pharmacology, Antineoplastic Combined Chemotherapy Protocols -- toxicity, Benzenesulfonates -- adverse effects, Benzenesulfonates -- pharmacokinetics, Benzenesulfonates -- pharmacology, Benzenesulfonates -- toxicity, Clinical Trials as Topic, Drug Interactions, Humans, Neoplasms -- drug therapy, Pyridines -- adverse effects, Pyridines -- pharmacokinetics, Pyridines -- pharmacology, Pyridines -- toxicity, Chemotherapy, Combination, Phase I/II clinical trials, Solid tumors, Sorafenib, Targeted agent

وصف الملف: No full-text files

العلاقة: uri/info:doi/10.1007/s00280-007-0639-9; uri/info:pmid/18026728; uri/info:scp/38049019119; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53573Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53573Test

المؤلفون: Strumberg, Dirk, Awada, Ahmad, Hirte, Hal W, Clark, J W, Seeber, Siegfried, Piccart, P, Hofstra, E, Voliotis, Dimitris, Christensen, O, Brueckner, A, Schwartz, Brian

المصدر: European journal of cancer, 42 (4

مصطلحات موضوعية: Sciences bio-médicales et agricoles, Administration, Oral, Adolescent, Adult, Aged, Antineoplastic Agents -- adverse effects, Benzenesulfonates -- administration & dosage, Benzenesulfonates -- adverse effects, Clinical Trials, Phase I as Topic, Dose-Response Relationship, Drug, Drug Eruptions -- etiology, Exanthema -- chemically induced, Female, Humans, Male, Maximum Tolerated Dose, Middle Aged, Neoplasms -- drug therapy, Pyridines -- administration & dosage, Pyridines -- adverse effects, Treatment Outcome, BAY 43-9006, PDGFR inhibitor, Phase I studies, Pooled analysis, Raf kinase inhibition, Refractory solid tumours

وصف الملف: 1 full-text file(s): application/pdf

العلاقة: uri/info:doi/10.1016/j.ejca.2005.11.014; uri/info:pii/S0959-8049(05)01070-1; uri/info:pmid/16426838; uri/info:scp/32444439875; https://dipot.ulb.ac.be/dspace/bitstream/2013/53735/1/Elsevier_29068.pdfTest; http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53735Test

الإتاحة: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53735Test
https://dipot.ulb.ac.be/dspace/bitstream/2013/53735/1/Elsevier_29068.pdfTest

المصدر: Annals of oncology, 21 (6

مصطلحات الفهرس: Sciences humaines, Antineoplastic Agents -- adverse effects -- therapeutic use, Benzenesulfonates -- adverse effects -- therapeutic use, Biliary Tract Neoplasms -- complications -- drug therapy -- secondary -- surgery, Biliary Tract Surgical Procedures -- adverse effects, Carcinoma, Hepatocellular -- complications -- drug therapy -- pathology -- surgery, Disease Progression, Fatal Outcome, Hemobilia -- etiology, Humans, Liver Neoplasms -- complications -- drug therapy -- pathology -- surgery, Pyridines -- adverse effects -- therapeutic use, Stents -- adverse effects, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/139410/3/doi_122450.pdfTest
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/139410Test
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLLTest

المصدر: Annals of oncology, 21 (6

مصطلحات الفهرس: Sciences humaines, Antineoplastic Agents -- adverse effects -- therapeutic use, Benzenesulfonates -- adverse effects -- therapeutic use, Biliary Tract Neoplasms -- complications -- drug therapy -- secondary -- surgery, Biliary Tract Surgical Procedures -- adverse effects, Carcinoma, Hepatocellular -- complications -- drug therapy -- pathology -- surgery, Disease Progression, Fatal Outcome, Hemobilia -- etiology, Humans, Liver Neoplasms -- complications -- drug therapy -- pathology -- surgery, Pyridines -- adverse effects -- therapeutic use, Stents -- adverse effects, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: https://dipot.ulb.ac.be/dspace/bitstream/2013/139410/3/doi_122450.pdfTest
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/139410Test
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLLTest

المصدر: Cancer chemotherapy and pharmacology, 61 (4

مصطلحات الفهرس: Sciences bio-médicales et agricoles, Animals, Antineoplastic Agents -- adverse effects, Antineoplastic Agents -- pharmacokinetics, Antineoplastic Agents -- pharmacology, Antineoplastic Agents -- toxicity, Antineoplastic Combined Chemotherapy Protocols -- pharmacology, Antineoplastic Combined Chemotherapy Protocols -- toxicity, Benzenesulfonates -- adverse effects, Benzenesulfonates -- pharmacokinetics, Benzenesulfonates -- pharmacology, Benzenesulfonates -- toxicity, Clinical Trials as Topic, Drug Interactions, Humans, Neoplasms -- drug therapy, Pyridines -- adverse effects, Pyridines -- pharmacokinetics, Pyridines -- pharmacology, Pyridines -- toxicity, Chemotherapy, Combination, Phase I/II clinical trials, Solid tumors, Sorafenib, Targeted agent, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53573Test
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLLTest

المصدر: Cancer chemotherapy and pharmacology, 61 (4

مصطلحات الفهرس: Sciences bio-médicales et agricoles, Animals, Antineoplastic Agents -- adverse effects, Antineoplastic Agents -- pharmacokinetics, Antineoplastic Agents -- pharmacology, Antineoplastic Agents -- toxicity, Antineoplastic Combined Chemotherapy Protocols -- pharmacology, Antineoplastic Combined Chemotherapy Protocols -- toxicity, Benzenesulfonates -- adverse effects, Benzenesulfonates -- pharmacokinetics, Benzenesulfonates -- pharmacology, Benzenesulfonates -- toxicity, Clinical Trials as Topic, Drug Interactions, Humans, Neoplasms -- drug therapy, Pyridines -- adverse effects, Pyridines -- pharmacokinetics, Pyridines -- pharmacology, Pyridines -- toxicity, Chemotherapy, Combination, Phase I/II clinical trials, Solid tumors, Sorafenib, Targeted agent, info:eu-repo/semantics/article, info:ulb-repo/semantics/articlePeerReview, info:ulb-repo/semantics/openurl/article

URL: http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53573Test
http://worldcat.org/search?q=on:EQY+http://difusion-oai.ulb.ac.be/oai/request+DCG_ENTIRE_REPOSITORY+CNTCOLLTest